Literature DB >> 20519456

Splicing of influenza A virus NS1 mRNA is independent of the viral NS1 protein.

Nicole C Robb1, David Jackson, Frank T Vreede, Ervin Fodor.   

Abstract

RNA segment 8 (NS) of influenza A virus encodes two proteins. The NS1 protein is translated from the unspliced primary mRNA transcript, whereas the second protein encoded by this segment, NS2/NEP, is translated from a spliced mRNA. Splicing of influenza NS1 mRNA is thought to be regulated so that the levels of NS2 spliced transcripts are approximately 10 % of total NS mRNA. Regulation of splicing of the NS1 mRNA has been studied at length, and a number of often-contradictory control mechanisms have been proposed. In this study, we used (32)P-labelled gene-specific primers to investigate influenza A NS1 mRNA splicing regulation. It was found that the efficiency of splicing of NS1 mRNA was maintained at similar levels in both virus infection and ribonucleoprotein-reconstitution assays, and NS2 mRNA comprised approximately 15 % of total NS mRNA in both assays. The effect of NS1 protein expression on the accumulation of viral NS2 mRNA and spliced cellular beta-globin mRNA was analysed, and it was found that NS1 protein expression reduced spliced beta-globin mRNA levels, but had no effect on the accumulation of NS2 mRNA. We conclude that the NS1 protein specifically inhibits the accumulation of cellular RNA polymerase II-driven mRNAs, but does not affect the splicing of its own viral NS1 mRNA.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20519456     DOI: 10.1099/vir.0.022004-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  24 in total

1.  Establishment of a chimeric, replication-deficient influenza A virus vector by modulation of splicing efficiency.

Authors:  Markus Wolschek; Elisabeth Samm; Helena Seper; Sanda Sturlan; Irina Kuznetsova; Cornelia Schwager; Alexandra Khassidov; Christian Kittel; Thomas Muster; Andrej Egorov; Michael Bergmann
Journal:  J Virol       Date:  2010-12-22       Impact factor: 5.103

2.  Modeling the intracellular dynamics of influenza virus replication to understand the control of viral RNA synthesis.

Authors:  Frank S Heldt; Timo Frensing; Udo Reichl
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

3.  The influenza A virus NS1 protein interacts with the nucleoprotein of viral ribonucleoprotein complexes.

Authors:  Nicole C Robb; Geoffrey Chase; Katja Bier; Frank T Vreede; Pang-Chui Shaw; Nadia Naffakh; Martin Schwemmle; Ervin Fodor
Journal:  J Virol       Date:  2011-03-16       Impact factor: 5.103

4.  hnRNP A2/B1 interacts with influenza A viral protein NS1 and inhibits virus replication potentially through suppressing NS1 RNA/protein levels and NS1 mRNA nuclear export.

Authors:  Yimeng Wang; Jianhong Zhou; Yuchun Du
Journal:  Virology       Date:  2013-11-26       Impact factor: 3.616

Review 5.  Species-Specific Host-Virus Interactions: Implications for Viral Host Range and Virulence.

Authors:  Stefan Rothenburg; Greg Brennan
Journal:  Trends Microbiol       Date:  2019-10-06       Impact factor: 17.079

Review 6.  Switch from protective to adverse inflammation during influenza: viral determinants and hemostasis are caught as culprits.

Authors:  Fatma Berri; Vuong Ba Lê; Martine Jandrot-Perrus; Bruno Lina; Béatrice Riteau
Journal:  Cell Mol Life Sci       Date:  2013-10-04       Impact factor: 9.261

7.  Influenza A virus attenuation by codon deoptimization of the NS gene for vaccine development.

Authors:  Aitor Nogales; Steven F Baker; Emilio Ortiz-Riaño; Stephen Dewhurst; David J Topham; Luis Martínez-Sobrido
Journal:  J Virol       Date:  2014-06-25       Impact factor: 5.103

8.  Influenza A virus utilizes suboptimal splicing to coordinate the timing of infection.

Authors:  Mark A Chua; Sonja Schmid; Jasmine T Perez; Ryan A Langlois; Benjamin R Tenoever
Journal:  Cell Rep       Date:  2013-01-17       Impact factor: 9.423

9.  Rearrangement of Influenza Virus Spliced Segments for the Development of Live-Attenuated Vaccines.

Authors:  Aitor Nogales; Marta L DeDiego; David J Topham; Luis Martínez-Sobrido
Journal:  J Virol       Date:  2016-06-24       Impact factor: 5.103

10.  Segment-specific kinetics of mRNA, cRNA and vRNA accumulation during influenza infection.

Authors:  Thu Phan; Elizabeth J Fay; Zion Lee; Stephanie Aron; Wei-Shou Hu; Ryan A Langlois
Journal:  J Virol       Date:  2021-03-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.